UBS Group set a €27.00 ($32.14) price target on Evonik Industries (FRA:EVK) in a report issued on Monday, www.boersen-zeitung.de reports. The firm currently has a sell rating on the stock.
Other equities analysts also recently issued research reports about the company. DZ Bank reiterated a neutral rating on shares of Evonik Industries in a research report on Friday, November 3rd. Goldman Sachs Group set a €29.00 ($34.52) target price on Evonik Industries and gave the company a neutral rating in a research report on Monday, November 6th. Berenberg Bank set a €33.00 ($39.29) target price on Evonik Industries and gave the company a buy rating in a research report on Friday, September 15th. Kepler Capital Markets set a €31.00 ($36.90) target price on Evonik Industries and gave the company a neutral rating in a research report on Friday, November 3rd. Finally, Barclays set a €34.50 ($41.07) target price on Evonik Industries and gave the company a buy rating in a research report on Friday, September 29th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average price target of €33.87 ($40.32).
Evonik Industries (FRA:EVK) opened at €31.03 ($36.94) on Monday. The stock has a market capitalization of $14,400.00 and a P/E ratio of 19.76. Evonik Industries has a 1 year low of €26.78 ($31.88) and a 1 year high of €32.97 ($39.25).
Evonik Industries Company Profile
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.